Related Experiment Video
Updated: May 10, 2026

Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
Suppression of malignancy by Smad3 in mouse embryonic stem cell formed teratoma
Peng Li1, Ying Chen, Xiaoming Meng
1Department of Chemical Pathology, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China.
Abstract:
Disease associated gene deficient embryonic stem cells can serve as valuable in vitro models to study disease mechanisms and screen drugs. Smad3 mediated TGF-β/Activin/Nodal signaling plays important roles in many biological processes. Despite numerous studies regarding Smad3 function, the role of Smad3 in mouse ES cells is not well studied. To understand the function of Smad3 in mouse ES cells, we derived Smad3-/- ES cells and wild type ES cells. Smad3-/- ES cells display no defect on self-renewal. They express similar level of pluripotent genes and lineage genes compared to wild type ES cells. However, Smad3 ablation results in transient difference in germ layer marker expression during embryoid body formation. Mesoderm lineage marker expression is significantly reduced in the embryoid body formed by Smad3-/- ES cells compared to wild type ES cells. Intriguingly, subcutaneous injection of Smad3-/- ES cells into nude mice leads to formation of malignant immature teratomas, whilst wild type ES cells tend to form mature teratomas. Smad3-/- ES cell formed teratomas can therefore provide a new model for the study of the mechanism of malignant teratomas.
Insights
Smad3 deficient mouse embryonic stem cells (ES cells) maintain self-renewal but show altered mesoderm development. These Smad3-/- ES cells form malignant teratomas, offering a new model for studying these tumors.
Area of Science:
- Developmental Biology
- Stem Cell Biology
- Cancer Biology
Background:
- Smad3-mediated transforming growth factor-beta (TGF-β)/Activin/Nodal signaling is crucial in biological processes.
- The specific role of Smad3 in mouse embryonic stem cells (ES cells) remains underexplored.
- Understanding Smad3 function in ES cells is vital for disease modeling and drug screening.
Purpose of the Study:
- To investigate the function of Smad3 in mouse ES cells.
- To characterize the developmental potential and tumorigenic properties of Smad3-deficient ES cells.
Main Methods:
- Derivation and characterization of Smad3 knockout (Smad3-/-) and wild-type (WT) mouse ES cells.
- Assessment of self-renewal and pluripotent gene expression.
- Analysis of germ layer marker expression during embryoid body (EB) formation.
- In vivo tumorigenicity assay via subcutaneous injection into nude mice.
Main Results:
- Smad3-/- ES cells exhibit normal self-renewal and pluripotent gene expression.
- A transient reduction in mesoderm lineage marker expression was observed in EBs derived from Smad3-/- ES cells.
- Subcutaneous injection of Smad3-/- ES cells resulted in the formation of malignant immature teratomas, unlike mature teratomas from WT ES cells.
Conclusions:
- Smad3 is not essential for mouse ES cell self-renewal but influences mesoderm differentiation.
- Smad3 deficiency in ES cells promotes the development of malignant teratomas.
- Smad3-/- ES cells provide a novel in vitro and in vivo model for studying malignant teratoma mechanisms.
Related Concept Videos
Abnormal Proliferation
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

